<DOC>
	<DOCNO>NCT00295802</DOCNO>
	<brief_summary>The purpose study determine substantial equivalence Ablatherm high intensity focus ultrasound ( HIFU ) compare cryotherapy treatment low risk , localized prostate cancer .</brief_summary>
	<brief_title>Ablatherm Integrated Imaging High Intensity Focused Ultrasound Indication Low Risk , Localized Prostate Cancer</brief_title>
	<detailed_description>Primary hypothesis clinical investigation HIFU Ablatherm Integrated Imaging non-inferior minimally invasive cryosurgery effective treatment method low risk , localized prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Diagnosis prostate cancer confirm PSA prostate biopsy Male subject , age equal 50 year Organconfined prostate cancer , clinical stage T1a , b , c T2a At least one positive biopsy within previous 6 month PSA equal less 10 ng/ml Gleason score equal less 6 Histological grade 3+3 , 3+2 , 2+3 , 2+4 , 2+2 base upon baseline transrectal ultrasound ( TRUS ) guide 10 core biopsy result . A subject histological grading primary 4 permit study enrollment . Prostate volume equal le 40 cc Prostate anteroposterior ( AP ) diameter equal less 25 mm Normal rectal anatomy rectal mucosa Maximum rectal wall measurement 6 mm The Investigator complete medical history physical examination assure subject meet study enrollment criteria The subject willing able read , understand , sign study specific informed consent form The subject agree comply study protocol requirement , include HIFU cryotherapy treatment follow visit requirement 24 month follow treatment . Evidence seminal vesicle involvement Evidence lymph node involvement metastasis Any previous treatment prostate cancer include : external beam radiation therapy ( EBRT ) , hormone therapy and/or previous bilateral orchiectomy Previous surgery procedure prostate ( except prostate biopsy ) urethra within prior one year Calcification inducing shadow prostate include targeted volume Large median lobe prostate include target volume Use within previous 2 month finasteride Previous rectal surgery ( hemorrhoidectomy ) history rectal disease Active inflammatory bowel syndrome Current superficial bladder cancer , urethral stricture , bladder neck contracture Active urinary tract infection prostatitis ( subject may enrol infection treat resolve ) Compromised renal function upper urinary tract disease result urinary obstruction A history bleed disorders/coagulopathy ongoing treatment condition Urinary tract rectal fistula Rectal fibrosis , rectal stenosis , anomaly make Ablatherm Integrated Imaging rectal probe insertion difficult Anatomical anomaly rectum anomaly rectal mucous membrane Prostate seroma , prostate abscess , urethral stenosis An intraprostatic implant stent catheter , implant prosthesis le 1 cm prostate Interest future fertility Concurrent illness , disability , geographical residence would hamper attendance require study visit Known latex hypersensitivity Current participation another clinical investigation medical device drug participate study within 30 day prior study enrollment The Investigator believe subject unwilling unable comply study protocol requirement , include HIFU cryotherapy procedure studyrelated follow visit requirement .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>HIFU</keyword>
	<keyword>EDAP</keyword>
	<keyword>Low Risk , Localized Prostate Cancer</keyword>
</DOC>